Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   540,054    

Indirect Shares

  247,533      
Direct Value   $43,092,104    

Indirect Value

  $21,938,850      
Total Shares   787,587      
Total Value   $65,030,954      


Biomarin Pharmaceutical Inc
 $41,992,185 Neurogesx Inc
 $0 Portola Pharmaceuticals Inc
 $12,729 Immunic Inc
 $23,125 Incyte Corp
 $914,552 Immunome Inc.
 $149,513 Keros Therapeutics, Inc.
 $0 Biomarin Pharmaceutical Inc
 $41,992,185 Neurogesx Inc
 $0 Portola Pharmaceuticals Inc
 $12,729 Immunic Inc
 $23,125 Incyte Corp
 $914,552 Immunome Inc.
 $149,513 Keros Therapeutics, Inc.
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    2   
    1    

     Stock price went up :

    1   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -13.1%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM 2024-05-21 9,615 0    Premium*  
            Keros Therapeutics, Inc. KROS 2024-06-01 200 0    Premium*  
* Premium Members only  

Records found :    853         Free Registration Required For Full Results.    Limit: 25

Download
  Page 14 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2011-08-30 4 S $29.01 $58,018 D/D (2,000) 127,093 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-03-01 4 AS $59.14 $59,140 D/D (1,000) 119,401 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-06-03 4 S $59.88 $59,876 D/D (1,000) 179,257 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2010-08-30 4 S $20.71 $62,126 D/D (3,000) 99,067 0 -
INCY Incyte Corp Director   –       •      –    2017-04-28 4 AB $124.26 $62,130 D/D 500 3,677 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-06-04 4 S $62.52 $62,521 D/D (1,000) 178,257 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2010-09-01 4 AS $21.00 $63,000 D/D (3,000) 96,067 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-07-15 4 OE $63.70 $63,698 I/I 1,000 48,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-04-30 4 S $63.74 $63,742 D/D (1,000) 119,317 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-08-15 4 S $64.36 $64,364 I/I (1,000) 48,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-12-26 4 OE $21.51 $64,530 D/D 3,000 330,530 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-01-07 4 OE $21.51 $64,530 D/D 3,000 330,530 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2007-06-01 4 OE $6.46 $64,600 D/D 10,000 25,695 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2007-08-17 4 OE $6.46 $64,600 D/D 10,000 16,695 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2007-09-19 4 OE $6.46 $64,600 D/D 10,000 16,695 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2007-09-25 4 OE $6.46 $64,600 D/D 10,000 16,695 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2008-05-02 4 OE $6.46 $64,600 D/D 10,000 21,120 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-12-04 4 OE $12.99 $64,950 D/D 5,000 172,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-12-12 4 OE $12.99 $64,950 D/D 5,000 172,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-12-31 4 OE $12.99 $64,950 D/D 5,000 172,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-01-18 4 OE $12.99 $64,950 D/D 5,000 172,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-02-28 4 OE $12.99 $64,950 I/I 5,000 18,545 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-03-04 4 OE $12.99 $64,950 I/I 5,000 23,545 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-06-12 4 OE $12.99 $64,950 I/I 5,000 48,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-11-05 4 OE $12.99 $64,950 I/I 5,000 50,740 0 -

  853  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14  15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35      
  Page 14 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed